Mechanistically, RYGB surgery activates AMPK and upregulates GLUT4, thus promoting tissue glucose uptake and metabolism, while AMPK cannot promote fatty acid oxidation through the STAT3 pathway under leptin receptor deficiency. The gene discussed is STAT3; the disease is hyperinsulinemic hypoglycemia, familial, 4.